DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,227,000 | -62.8% | 209,686 | -31.2% | 1.07% | -57.0% |
| Q2 2021 | $11,371,000 | +46.6% | 304,686 | +0.5% | 2.49% | +38.1% |
| Q1 2021 | $7,755,000 | +6.2% | 303,268 | -8.5% | 1.80% | -3.8% |
| Q4 2020 | $7,303,000 | +24.6% | 331,513 | +1.7% | 1.87% | +20.6% |
| Q3 2020 | $5,862,000 | -23.3% | 325,863 | +8.3% | 1.55% | -27.9% |
| Q2 2020 | $7,640,000 | +38.3% | 300,805 | 0.0% | 2.15% | -16.0% |
| Q1 2020 | $5,526,000 | +4.5% | 300,805 | +25.3% | 2.56% | +67.8% |
| Q4 2019 | $5,287,000 | – | 240,000 | – | 1.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |